Skip to main content
Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
36.28
-1.00 (-2.68%)
Mar 6, 2026, 9:35 AM EST - Market open

Collegium Pharmaceutical Revenue

In the year 2025, Collegium Pharmaceutical had annual revenue of $780.57M with 23.62% growth. Collegium Pharmaceutical had revenue of $205.45M in the quarter ending December 31, 2025, with 12.92% growth.

Revenue (ttm)
$780.57M
Revenue Growth
+23.62%
P/S Ratio
1.52
Revenue / Employee
$1,845,312
Employees
423
Market Cap
1.15B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025780.57M149.12M23.62%
Dec 31, 2024631.45M64.68M11.41%
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.25B
Evotec SE 887.40M
ANI Pharmaceuticals 883.37M
Tilray Brands 837.32M
Pacira BioSciences 726.41M
Amphastar Pharmaceuticals 719.89M
Alvotech 573.35M
Harrow 272.30M
Revenue Rankings

COLL News

More News